Zhongyun Dong, MD, PhD

Medical Degree: Anhui Medical University 1983

Master's Degree: Peking Union Medical College 1986 (Immunology)

Doctoral Degree: Peking Union Medical College 1989 (Immunology)

Fellowship: The University of Texas MD Anderson Cancer Center 1991

Prostate Cancer, IFN-b Gene Therapy, Angiogenesis, PCNA inhibitor, Androgen receptor inhibitor, Androgen receptor

1986 -1989 Assistant Professor, Department of Immunology, Cancer Institute, Chinese Academy of Medical Sciences, Beijing, P.R. of China

1991 -1993 Research Associate, Department of Cell Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

1994 -1997 Assistant Professor and Assistant Biologist, Department of Cell Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

1997 -2003 Assistant Professor and Assistant Biologist (tenure-track), Department of Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

2003 -2004 Associate Professor and Associate Biologist, Department of Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

2004 -2011 Associate Professor, Department of Internal Medicine, Division of Hematology-Oncology, University of Cincinnati College of Medicine, Cincinnati, OH

2011 -To Present Professor, Department of Internal Medicine, Division of Hematology-Oncology, University of Cincinnati, Cincinnati, OH

08-01-2012 -07-31-2014 NSF A pilot microfactory for Nonomedicine devices Role:Co-PI $817497 Active Type:Grant

03-01-2010 -02-28-2011 AREVA Med In vivo Evaluation of a single intravenous injection of AREVA agent in PC-3 orthotopic tumor model Role:PI

09-01-2008 -08-31-2013 NIH/NCI-R01 A novel androgen receptor antagonist Role:PI

Investigators:J Sankar, Z Dong 08-01-2008 -07-31-2013 NSF Revolutionizing Metallic Biomaterials Role:Co-I

2007 -2008 Interdisciplinary Faculty Research Support - UC Development of Luminescent Nanotubes for Cancer Diagnosis and Treatment Role:Co-PI

2006 -2007 UC Cancer Center Pilot Grant Development of Nanobiometric Sensor for detection of cytokines in cancers Role:PI

Grant: #RSG-98-332-04 Investigators:Dong, Zhongyun 07-01-2004 -06-30-2008 American Cancer Society - National Chapter A Novel Therapy for Locally Advanced Prostate Cancer Role:PI $720,000.00 Closed Level:Private Non-Profit

Grant: #R01 CA097099 Investigators:Dong, Zhongyun 08-20-2004 -03-31-2009 National Cancer Institute TGF-Beta 1-Regulated IL-8 Expression in Prostate Cancer Role:PI $1,122,863.00 Closed Level:Federal

Investigators:Dong, Zhongyun 04-01-2004 -12-31-2006 Department of Defense A Novel Therapy System for Occult Protstae Cancer Role:PI $559,223.00 Closed Level:Federal

Grant: #R01 CA131137 Investigators:Dong, Zhongyun; Khan, Sohaib; Lu, Shan; Wortman, Matthew 09-09-2008 -07-31-2014 National Cancer Institute A Novel Synthetic Androgen Receptor Antagonist Role:PI $1,599,078.00 Active Level:Federal

Grant: #260116B / EEC-0812348 Investigators:Behbehani, Michael; Butler, David; Dong, Zhongyun; Halsall, H Brian; Heineman, William; Montemagno, Carlo; Schulz, Mark; Shanov, Vesselin 09-01-2008 -08-31-2014 National Science Foundation Responsive Biosensors for Implants Role:Collaborator $3,800,000.00 Active Level:Federal

Grant: #SRS 006743 Investigators:Dong, Zhongyun; Rixe, Olivier 02-11-2010 -02-28-2012 AREVA Med, LLC. In Vivo Evaluation of a Single Intravenous Injection of AREVA Agent in PC-3 Orthotopic Tumor Model Role:Collaborator $180,000.00 Closed Level:Industry

Grant: #W81XWH-10-1-0367 Investigators:Choubey, Divaker; Dong, Zhongyun; Tarapore, Pheruza 05-15-2010 -05-14-2014 Department of the Army Medical Research and Materiel Command Targeted Delivery of Therapeutic RNA into Prostate Cancers Role:Collaborator $353,250.00 Active Level:Federal

Grant: #CBET-1239779 Investigators:Dong, Zhongyun; Mast, David; Meenakshi, Sundaram Murali; Schulz, Mark; Shanov, Vesselin 09-01-2012 -08-31-2014 National Science Foundation A Pilot Microfactory for Nanomedicine Devices Role:Collaborator $498,084.00 Active Level:Federal

Grant: #OBR Action Fund #994 Investigators:Dong, Zhongyun; Mast, David; Meenakshi, Sundaram Murali; Schulz, Mark; Shanov, Vesselin 07-01-2012 -06-30-2014 Ohio Board of Regents A Pilot Microfactory for Nanomedicine Devices Role:Collaborator $80,000.00 Active Level:State of Ohio

Grant: #W81XWH-10-1-0367 Investigators:Choubey, Divaker; Dong, Zhongyun; Tarapore, Pheruza 05-15-2010 -05-14-2014 Department of the Army Medical Research and Materiel Command Targeted Delivery of Therapeutic RNA into Prostate Cancers Role:Collaborator $353,250.00 Closed Level:Federal

Grant: #R21CA223049 Investigators:Dong, Zhongyun; Lu, Shan 08-01-2018 -07-31-2020 National Cancer Institute Preclinical safety and efficacy assessment of a novel PCNA inhibitor for prostate cancer therapy Role:PI $208,854.00 Active Level:Federal

Grant: #IIP-2016475 Investigators:Dong, Zhongyun; Heineman, William; Zhang, Peng 09-01-2020 -08-31-2022 National Science Foundation Development of visual hydrogen sensor for non-invasive monitoring of biodegradable metal implants Role:Collaborator $249,987.00 Awarded Level:Federal

Grant: #R21CA256009 Investigators:Dong, Zhongyun 01-01-2022 -12-31-2023 National Cancer Institute Proliferating cell nuclear antigen in regulation of androgen receptor signalings in castration-resistant prostate cancer cells Role:PI 227205.00 Awarded Level:Federal

Grant: #W81XWH-22-1-0815 Investigators:Dong, Zhongyun; Lu, Shan 09-30-2022 -09-29-2025 Department of the Army Medical Research Acquisition Activity Targeting proliferating cell nuclear antigen for enhancing efficacy of radiotherapy in prostate cancer Role:PI 1164481.00 Active Level:Federal

Peer Reviewed Publications

Dong, Zhongyun; Meller, Jaroslaw; Succop, Paul; Wang, Jiang; Wikenheiser-Brokamp, Kathryn; Starnes, Sandra; Lu, Shan  (2014). Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells. International journal of oncology, 45 (3) , 978-84More Information

Hong, Daeho; Saha, Partha; Chou, Da-Tren; Lee, Boeun; Collins, Boyce E; Tan, Zongqing; Dong, Zhongyun; Kumta, Prashant N  (2013). In vitro degradation and cytotoxicity response of Mg-4% Zn-0.5% Zr (ZK40) alloy as a potential biodegradable material. Acta biomaterialia, 9 (10) , 8534-47More Information

Chou, Da-Tren; Hong, Daeho; Saha, Partha; Ferrero, Jordan; Lee, Boeun; Tan, Zongqing; Dong, Zhongyun; Kumta, Prashant N  (2013). In vitro and in vivo corrosion, cytocompatibility and mechanical properties of biodegradable Mg-Y-Ca-Zr alloys as implant materials. Acta biomaterialia, 9 (10) , 8518-33More Information

Xue, D., Yun Y., Tan Z., Dong Z., and M. J. Schultz  (2012). In Vivo and In Vitro degradation behavior of magnesium alloys as biomaterials. J. Mat. Sci. Tech.

Oleksowicz, L., Jiu, Y., Bracken, R.B, Gaitonde, K., Burke, B., Succop, P., Levin, L., Dong, Z., and Lu,S.  (2012). Secretory Phospholipase A2-lla is a Target Gene of the HER/HER2-Elicited Pathway and Potential Plasma Biomarket for Poor Prognosis of Prostate Cancer. Prostate, 72, 1140-49

Yun, Y., Pixley, S., X. Cui, T., Dong, Z., Collins, B., Shanov, V., Ko, S., Pai1, D., Yarmolenko, S., Schulz, M. J., and J. Sankar  (2012). Carbon Nanomaterials: From Therapeutics to Regenerative Medicine. Nanomedicine and Biotherapeutic Discovery, 2, 1000104

Tan, Z., Chen, P., Schneider, N., Glover, S., Cui, L., Torgue, J., Rixe, O., Spitz, H. B., an Dong, Z.  (2012). Significant systemic therapeutic effects of high-LET immunoradiation by Pb-trastuzumab against prostatic tumors of androgen-independent human prostate cancer in mice. Int J. Oncol, 40, 1881-1888

Cui, L., Dillehay, K. L., Chen, W., Shen, D., Dong, Z., W. Li  (2012). Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis. Mol Biol Reports, 39, 7465-71

Cui, L., Chen, P., Tan, Z., and Dong, Z.  (2012). Hemostatic gelatin sponge is a superior matrix to Matrigel for estabishment of LNCaP human prostate cancer in nude mice. Prostate, DOI:10 (1002/) , pros. 22520

Tan, Z., Wortman, M., Dillehay, K.L., Seibel, W., Evelyn, C. R., Smith, S. J., Malkas, L., Zheng, Y., Lu, S., and Dong, Z.  (2012). Small molecule targeting of PCNA chromatin association inhibits tumor cell growth. Mol Pharmacol, 81, 811-9

Cui, Lingling; Chen, Pingping; Tan, Zongqing; Li, Wenjie; Dong, Zhongyun  (2012). Hemostatic gelatin sponge is a superior matrix to matrigel for establishment of LNCaP human prostate cancer in nude mice. The Prostate, 72 (15) , 1669-77More Information

Oleksowicz, Leslie; Liu, Yin; Bracken, R Bruce; Gaitonde, Krishnanath; Burke, Barbara; Succop, Paul; Levin, Linda; Dong, Zhongyun; Lu, Shan  (2012). Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer. The Prostate, 72 (10) , 1140-9More Information

Tan, Zongqing; Chen, Pingping; Schneider, Nathan; Glover, Samuel; Cui, Lingling; Torgue, Julien; Rixe, Olivier; Spitz, Henry B; Dong, Zhongyun  (2012). Significant systemic therapeutic effects of high-LET immunoradiation by 212Pb-trastuzumab against prostatic tumors of androgen-independent human prostate cancer in mice. International journal of oncology, 40 (6) , 1881-8More Information

Tan, Zongqing; Wortman, Matthew; Dillehay, Kelsey L; Seibel, William L; Evelyn, Chris R; Smith, Shanna J; Malkas, Linda H; Zheng, Yi; Lu, Shan; Dong, Zhongyun  (2012). Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth. Molecular pharmacology, 81 (6) , 811-9More Information

Kupert, Elena; Anderson, Marshall; Liu, Yin; Succop, Paul; Levin, Linda; Wang, Jiang; Wikenheiser-brokamp, Kathryn; Chen, Pingping; Pinney, Susan M; Macdonald, Trudy; Dong, Zhongyun; Starnes, Sandra; Lu, Shan  (2011). Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules. BMC cancer, 11, 513More Information

Kupert, E., Anderson, M. Liu, Y., Succop, P., Levin, L., Wang, J., Wikenheisser-Brokamp, K., Chen, P., Ponney, S., Macdonald, T., Dong, Z., Starnes, S. and Lu, S.  (2011). Plasma secretory phospholipase A2-lla as a potential biomarker for lung cancer in patients with solitary pulmonary nodules. BMC Cancer, 11, 513

Dong, Zhongyun; Liu, Yin; Levin, Linda; Oleksowicz, Leslie; Wang, Jiang; Lu, Shan  (2011). Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer. Oncology reports, 25 (6) , 1511-6More Information

Meng, Qinghang; Peng, Zhimin; Chen, Liang; Si, Jutong; Dong, Zhongyun; Xia, Ying  (2010). Nuclear Factor-?B modulates cellular glutathione and prevents oxidative stress in cancer cells. Cancer letters, 299 (1) , 45-53More Information

Lu, Shan; Tan, Zongqin; Wortman, Matthew; Lu, Shan; Dong, Zhongyun  (2010). Preferential induction of G1 arrest in androgen-responsive human prostate cancer cells by androgen receptor signaling antagonists DL3 and antiandrogen bicalutamide. Cancer letters, 298 (2) , 250-7More Information

Dong, Zhongyun; Liu, Yin; Scott, Kieran F; Levin, Linda; Gaitonde, Krishnanath; Bracken, R Bruce; Burke, Barbara; Zhai, Qihui Jim; Wang, Jiang; Oleksowicz, Leslie; Lu, Shan  (2010). Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer. Carcinogenesis, 31 (11) , 1948-55More Information

Cho, Hoon-Sung; Dong, Zhongyun; Pauletti, Giovanni M; Zhang, Jiaming; Xu, Hong; Gu, Hongchen; Wang, Lumin; Ewing, Rodney C; Huth, Christopher; Wang, Feng; Shi, Donglu  (2010). Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment. ACS nano, 4 (9) , 5398-404More Information

Yun, YeoHeung; Dong, Zhongyun; Tan, Zongqing; Schulz, Mark J  (2010). Development of an electrode cell impedance method to measure osteoblast cell activity in magnesium-conditioned media. Analytical and bioanalytical chemistry, 396 (8) , 3009-15More Information

Liu, Yin; Wu, Xiaoyang; Dong, Zhongyun; Lu, Shan  (2010). The molecular mechanism of Vav3 oncogene on upregulation of androgen receptor activity in prostate cancer cells. International journal of oncology, 36 (3) , 623-33

Lu, Shan; Tan, Zongqin; Wortman, Matt; Lu, Shan; Dong, Zhongyun  (2010). Regulation of heat shock protein 70-1 expression by androgen receptor and its signaling in human prostate cancer cells. International journal of oncology, 36 (2) , 459-67

Yun, Yeo-Heung; Eteshola, Edward; Bhattacharya, Amit; Dong, Zhongyun; Shim, Joon-Sub; Conforti, Laura; Kim, Dogyoon; Schulz, Mark J; Ahn, Chong H; Watts, Nelson  (2009). Tiny medicine: nanomaterial-based biosensors. Sensors (Basel, Switzerland), 9 (11) , 9275-99More Information

Guo, Yan; Shi, Donglu; Lian, Jie; Dong, Zhongyun; Wang, Wei; Cho, Hoonsung; Liu, Guokui; Wang, Lumin; Ewing, Rodney C  (2008). Quantum dot conjugated hydroxylapatite nanoparticles for in vivo imaging. Nanotechnology, 19 (17) , 175102More Information

Liu, Yin; Mo, Jun Qin; Hu, Qiande; Boivin, Gregory; Levin, Linda; Lu, Shan; Yang, Dianer; Dong, Zhongyun; Lu, Shan  (2008). Targeted overexpression of vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer. Cancer research, 68 (15) , 6396-406More Information

Lee, Kiwon; Liu, Yin; Mo, Jun Qin; Zhang, Jinsong; Dong, Zhongyun; Lu, Shan  (2008). Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer. BMC cancer, 8, 158More Information

Wang, Daren; Lu, Shan; Dong, Zhongyun  (2007). Regulation of TGF-beta1 gene transcription in human prostate cancer cells by nitric oxide. The Prostate, 67 (16) , 1825-33More Information

Yun, Yeoheung; Dong, Zhongyun; Shanov, Vesselin N; Schulz, Mark J  (2007). Electrochemical impedance measurement of prostate cancer cells using carbon nanotube array electrodes in a microfluidic channel. Nanotechnology, 18 (46) , 465505More Information

Lu, Shan; Lee, Juwon; Revelo, Monica; Wang, Xiaohong; Lu, Shan; Dong, Zhongyun  (2007). Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice. Clinical cancer research : an official journal of the American Association for Cancer Research, 13 (19) , 5692-702More Information

Yun, YeoHeung; Bange, Adam; Shanov, Vesselin N; Heineman, William R; Halsall, H Brian; Dong, Zhongyun; Jazieh, Abdul; Tu, Yi; Wong, Danny; Pixley, Sarah; Behbehani, Michael; Schulz, Mark J  (2007). A carbon nanotube needle biosensor. Journal of nanoscience and nanotechnology, 7 (7) , 2293-300

Lu, Shan; Wang, Amy; Lu, Shan; Dong, Zhongyun  (2007). A novel synthetic compound that interrupts androgen receptor signaling in human prostate cancer cells. Molecular cancer therapeutics, 6 (7) , 2057-64More Information

Yun, Yeoheung; Gollapudi, Ram; Shanov, Vesselin; Schulz, Mark J; Dong, Zhongyun; Jazieh, Abdul; Heineman, William R; Halsall, H Brian; Wong, Danny K Y; Bange, Adam; Tu, Yi; Subramaniam, Srinivas  (2007). Carbon nanotubes grown on stainless steel to form plate and probe electrodes for chemical/biological sensing. Journal of nanoscience and nanotechnology, 7 (3) , 891-7

Lee, Juwon; Wang, Amy; Hu, Qiande; Lu, Shan; Dong, Zhongyun  (2006). Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice. International journal of oncology, 29 (6) , 1405-12

Dong, Zhongyun; Liu, Yin; Lu, Shan; Wang, Amy; Lee, Kiwon; Wang, Lu-Hai; Revelo, Monica; Lu, Shan  (2006). Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer. Molecular endocrinology (Baltimore, Md.), 20 (10) , 2315-25More Information

Lu, Shan; Dong, Zhongyun  (2006). Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells. The Prostate, 66 (9) , 996-1004More Information

Zhang, Fahao; Lee, Juwon; Wang, Daren; Dong, Zhongyun  (2006). Differential growth of IFN-beta-engineered tumor cells in nude and IFN receptor-null mice. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 26 (2) , 108-18More Information

Liu, Guozhen; Zhang, Fahao; Lee, Juwon; Dong, Zhongyun  (2005). Selective induction of interleukin-8 expression in metastatic melanoma cells by transforming growth factor-beta 1. Cytokine, 31 (3) , 241-9More Information

Zhang, Fahao; Lee, Juwon; Lu, Shan; Pettaway, Curtis A; Dong, Zhongyun  (2005). Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Clinical cancer research : an official journal of the American Association for Cancer Research, 11 (12) , 4512-20More Information

Uehara, Hisanori; Troncoso, Patricia; Johnston, Dennis; Bucana, Corazon D; Dinney, Colin; Dong, Zhongyun; Fidler, Isaiah J; Pettaway, Curtis A  (2005). Expression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stage. The Prostate, 64 (1) , 40-9More Information

Ozawa, Shutaro; Lu, Weixin; Bucana, Corazon D; Kanayama, Hiro-Omi; Shinohara, Hisashi; Fidler, Isaiah J; Dong, Zhongyun  (2003). Regression of primary murine colon cancer and occult liver metastasis by intralesional injection of lyophilized preparation of insect cells producing murine interferon-beta. International journal of oncology, 22 (5) , 977-84

Lu, Weixin; Su, Jindong; Kim, Lee Su; Bucana, Corazon D; Donawho, Cherrie; He, Junqing; Fidler, Isaiah J; Dong, Zhongyun  (2003). Active specific immunotherapy against occult brain metastasis. Cancer research, 63 (6) , 1345-50

Harmey, Judith H; Bucana, Corazon D; Lu, Weixin; Byrne, Anne Marie; McDonnell, Susan; Lynch, Conor; Bouchier-Hayes, David; Dong, Zhongyun  (2002). Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. International journal of cancer. Journal international du cancer, 101 (5) , 415-22More Information

Zhang, Fahao; Lu, Weixin; Dong, Zhongyun  (2002). Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice. Clinical cancer research : an official journal of the American Association for Cancer Research, 8 (9) , 2942-51

Lu, Weixin; Dong, Zhongyun; Donawho, Cherrie; Fidler, Isaiah J  (2002). Specific immunotherapy against occult cancer metastases. International journal of cancer. Journal international du cancer, 100 (4) , 480-5More Information

Takeuchi, Osamu; Sato, Shintaro; Horiuchi, Takao; Hoshino, Katsuaki; Takeda, Kiyoshi; Dong, Zhongyun; Modlin, Robert L; Akira, Shizuo  (2002). Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. Journal of immunology (Baltimore, Md. : 1950), 169 (1) , 10-4

Makar, Tapas Kumar; Wilt, Susan; Dong, Zhongyun; Fishman, Paul; Mouradian, M Maral; Dhib-Jalbut, Suhayl  (2002). IFN-beta gene transfer into the central nervous system using bone marrow cells as a delivery system. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 22 (7) , 783-91More Information

Davies, Michael A; Kim, Sun J; Parikh, Nila U; Dong, Zhongyun; Bucana, Corazon D; Gallick, Gary E  (2002). Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 8 (6) , 1904-14

Izawa, Jonathan I; Sweeney, Paul; Perrotte, Paul; Kedar, Daniel; Dong, Zhongyun; Slaton, Joel W; Karashima, Takashi; Inoue, Keji; Benedict, William F; Dinney, Colin P N  (2002). Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis. Clinical cancer research : an official journal of the American Association for Cancer Research, 8 (4) , 1258-70

Zhao D.;Wu J.;Chou D.T.;Hoagland W.;Benson D.;Dong Z.;Kumta P.N.;Heineman W.R.  (01-01-2020). Visual Hydrogen Mapping Sensor for Noninvasive Monitoring of Bioresorbable Magnesium Implants In Viv. JOMMore Information

Lu S.;Dong Z.  (01-01-2019). Additive effects of a small molecular PCNA inhibitor PCNA-I1S and DNA damaging agents on growth inhi. PLoS ONE, 14 (10) More Information

Yin Z.;Dong Z.;Cahay M.;Pixley S.;Haworth K.J.;Rahimi M.;Goh S.K.;Starnes S.;Patwardhan M.;Chaudhary S.;Schulz M.J.  (01-01-2019). Carbon nanotube wire for use in precision medical devices. Nanotube Superfiber Materials: Science, Manufacturing, Commercialization, 825-849More Information

Wu J.;Zhao D.;Ohodnicki J.M.;Lee B.;Roy A.;Yao R.;Chen S.;Dong Z.;Heineman W.R.;Kumta P.N.  (03-12-2018). In Vitro and in Vivo Evaluation of Multiphase Ultrahigh Ductility Mg-Li-Zn Alloys for Cardiovascular. ACS Biomaterials Science and Engineering, 4 (3) , 919-932More Information

Koo Y.;Lee H.;Dong Z.;Kotoka R.;Sankar J.;Huang N.;Yun Y.  (12-01-2017). The Effects of Static and Dynamic Loading on Biodegradable Magnesium Pins in Vitro and in Vivo. Scientific Reports, 7 (1) More Information

Zhao D.;Wang T.;Nahan K.;Guo X.;Zhang Z.;Dong Z.;Chen S.;Chou D.;Hong D.;Kumta P.;Heineman W.  (03-01-2017). In vivo characterization of magnesium alloy biodegradation using electrochemical H2. Acta Biomaterialia, 50, 556-565More Information

Zhao D.;Wang T.;Hoagland W.;Benson D.;Dong Z.;Chen S.;Chou D.;Hong D.;Wu J.;Kumta P.;Heineman W.  (11-01-2016). Visual H2 sensor for monitoring biodegradation of magnesium implants in vivo. Acta Biomaterialia, 45, 399-409More Information

Zhao D.;Wang T.;Kuhlmann J.;Dong Z.;Chen S.;Joshi M.;Salunke P.;Shanov V.;Hong D.;Kumta P.;Heineman W.  (05-01-2016). In vivo monitoring the biodegradation of magnesium alloys with an electrochemical H2. Acta Biomaterialia, 36, 361-368More Information

Zhao D.;Wang T.;Guo X.;Kuhlmann J.;Doepke A.;Dong Z.;Shanov V.;Heineman W.  (04-01-2016). Monitoring Biodegradation of Magnesium Implants with Sensors. JOM, 68 (4) , 1204-1208More Information

Joshi M.;Salunke P.;Zhang G.;Chaswal V.;Dong Z.;Shanov V.  (09-04-2015). Magnesium Single Crystal as a Biodegradable Implant Material. Biomaterials Science: Processing, Properties and Applications V: Ceramic Transactions, Volume 254, 97-113More Information

Dillehay K.;Seibel W.;Zhao D.;Lu S.;Dong Z.  (03-01-2015). Target validation and structure-activity analysis of a series of novel PCNA inhibitors. Pharmacology Research and Perspectives, 3 (2) More Information

Jang Y.;Tan Z.;Jurey C.;Xu Z.;Dong Z.;Collins B.;Yun Y.;Sankar J.  (03-01-2015). Understanding corrosion behavior of Mg-Zn-Ca alloys from subcutaneous mouse model: Effect of Zn elem. Materials Science and Engineering C, 48, 28-40More Information

Smith S.J.;Gu L.;Phipps E.A.;Dobrolecki L.E.;Mabrey K.S.;Gulley P.;Dillehay K.L.;Dong Z.;Fields G.B.;Chen Y.R.;Ann D.;Hickey R.J.;Malkas L.H.  (02-01-2015). A peptide mimicking a region in proliferating cell nuclear antigen specific to key protein interacti. Molecular Pharmacology, 87 (2) , 263-276More Information

Joshi M.;Salunke P.;Zhang G.;Chaswal V.;Dong Z.;Shanov V.  (01-01-2015). Magnesium single crystal as a biodegradable implant material. Ceramic Transactions, 254, 97-113

Dillehay K.;Lu S.;Dong Z.  (12-01-2014). Antitumor effects of a novel small molecule targeting PCNA chromatin association in prostate cancer. Molecular Cancer Therapeutics, 13 (12) , 2817-2826More Information

Jang Y.;Tan Z.;Jurey C.;Collins B.;Badve A.;Dong Z.;Park C.;Kim C.S.;Sankar J.;Yun Y.  (12-01-2014). Systematic understanding of corrosion behavior of plasma electrolytic oxidation treated AZ31 magnesi. Materials Science and Engineering C, 45, 45-55More Information

Yun Y.;Jang Y.;Wang J.;Dong Z.;Shanov V.;Sankar J.;Koo Y.;White L.;Collins B.  (01-01-2014). Biodegradable magnesium implant: In vivo and in vitro convergence. ASME International Mechanical Engineering Congress and Exposition, Proceedings (IMECE), 14More Information

Schneider N.;Lobaugh M.;Tan Z.;Sandwall P.;Chen P.;Glover S.;Cui L.;Murry M.;Dong Z.;Torgue J.;Spitz H.  (04-01-2013). Biodistribution of ²¹²Pb conjugated trastuzumab in mice. Journal of Radioanalytical and Nuclear Chemistry, 296 (1) , 75-81More Information

Cui L.;Dillehay K.;Chen W.;Shen D.;Dong Z.;Li W.  (07-01-2012). Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: A meta-analysis. Molecular Biology Reports, 39 (7) , 7465-7471More Information

Xue D.;Tan Z.;Schulz M.;Vanooij W.;Sankar J.;Yun Y.;Dong Z.  (07-01-2012). Corrosion studies of modified organosilane coated magnesium-yttrium alloy in different environments. Materials Science and Engineering C, 32 (5) , 1230-1236More Information

Xue D.;Yun Y.;Tan Z.;Dong Z.;Schulz M.  (03-01-2012). In Vivo and In Vitro Degradation Behavior of Magnesium Alloys as Biomaterials. Journal of Materials Science and Technology, 28 (3) , 261-267More Information

Schulz M.;Doepke A.;Guo X.;Kuhlmann J.;Halsall B.;Heineman W.;Dong Z.;Tan Z.;Xue D.;Lee N.;Yun Y.;Liu Y.;Hurd D.;Shanov V.;Rai D.;Witte F.;Kumar D.;Yarmolenko S.;Pixley S.;Hopkins T.;Jayasinghe C.;Sundaramurthy S.  (01-01-2010). Responsive biosensors for biodegradable magnesium implants. ASME International Mechanical Engineering Congress and Exposition, Proceedings, 14, 109-116More Information

Shi D.;Cho H.;Huth C.;Wang F.;Dong Z.;Pauletti G.;Lian J.;Wang W.;Liu G.;Bud'Ko S.;Wang L.;Ewing R.  (12-18-2009). Conjugation of quantum dots and Fe3 O4 on carbon nanot. Applied Physics Letters, 95 (22) More Information

Yun Y.H.;Shanov V.N.;Bange A.;Heineman W.R.;Halsall H.B.;Seth G.;Pixley S.K.;Behbehani M.;Bhattacharya A.;Dong Z.;Yarmolenko S.;Kang I.;Schulz M.J.  (12-01-2009). Carbon nanotube smart materials for biology and medicine. NanoScience in Biomedicine, 451-484More Information

Yun Y.;Eteshola E.;Bhattacharya A.;Dong Z.;Shim J.;Conforti L.;Kim D.;Schulz M.;Ahn C.;Watts N.  (11-01-2009). Tiny medicine: Nanomaterial-based biosensors. Sensors, 9 (11) , 9275-9299More Information

Yun Y.;Dong Z.;Yang D.;Shanov V.;Yarmolenko S.;Xu Z.;Kumta P.;Sfeir C.;Doepke A.;Schulz M.  (09-17-2009). Biodegradable Mg for bone implants: Corrosion and osteoblast culture studies. ASME International Mechanical Engineering Congress and Exposition, Proceedings, 15, 125-129More Information

Yun Y.;Dong Z.;Yang D.;Schulz M.;Shanov V.;Yarmolenko S.;Xu Z.;Kumta P.;Sfeir C.  (08-01-2009). Biodegradable Mg corrosion and osteoblast cell culture studies. Materials Science and Engineering C, 29 (6) , 1814-1821More Information

Shi D.;Cho H.S.;Chen Y.;Xu H.;Gu H.;Lian J.;Wang W.;Liu G.;Huth C.;Wang L.;Ewing R.C.;Budko S.;Pauletti G.M.;Dong Z.  (06-05-2009). Fluorescent polystyrene-Fe3O4 composite nanospheres fo. Advanced Materials, 21 (21) , 2170-2173More Information

Yun Y.H.;Dong Z.;Tan Z.;Schulz M.J.;Shanov V.  (04-30-2009). Fibroblast cell behavior on chemically functionalized carbon nanomaterials. Materials Science and Engineering C, 29 (3) , 719-725More Information

Yun Y.;Dong Z.;Lee N.;Liu Y.;Xue D.;Guo X.;Kuhlmann J.;Doepke A.;Halsall H.;Heineman W.;Sundaramurthy S.;Schulz M.;Yin Z.;Shanov V.;Hurd D.;Nagy P.;Li W.;Fox C.  (01-01-2009). Revolutionizing biodegradable metals. Materials Today, 12 (10) , 22-32More Information

Guo Y.;Shi D.;Cho H.;Dong Z.;Kulkarni A.;Pauletti G.;Wang W.;Lian J.;Liu W.;Ren L.;Zhang Q.;Liu G.;Huth C.;Wang L.;Ewing R.  (09-10-2008). In vivo imaging and drug storage by quantum-dot-conjugated carbon nanotubes. Advanced Functional Materials, 18 (17) , 2489-2497More Information

Yun Y.;Dong Z.;Shanov V.;Doepke A.;Heineman W.;Halsall H.;Bhattacharya A.;Wong D.;Schulz M.  (07-28-2008). Fabrication and characterization of carbon nanotube array electrodes with gold nanoparticle tips. Sensors and Actuators, B: Chemical, 133 (1) , 208-212More Information

Guo Y.;Shi D.;Lian J.;Dong Z.;Wang W.;Cho H.;Liu G.;Wang L.;Ewing R.  (04-30-2008). Quantum dot conjugated hydroxylapatite nanoparticles for in vivo imaging. Nanotechnology, 19 (17) More Information

Shi D.;Guo Y.;Dong Z.;Lian J.;Wang W.;Liu G.;Wang L.;Ewing R.  (04-21-2008). Quantum-dot-activated luminescent carbon nanotubes via a nano scale surface functionalization for in. Advanced Materials, 20 (8) , 1More Information

Yun Y.H.;Dong Z.;Shanov V.;Heineman W.R.;Halsall H.B.;Bhattacharya A.;Conforti L.;Narayan R.K.;Ball W.S.;Schulz M.J.  (12-01-2007). Nanotube electrodes and biosensors. Nano Today, 2 (6) , 30-37More Information

Yun Y.;Dong Z.;Shanov V.;Schulz M.  (11-21-2007). Electrochemical impedance measurement of prostate cancer cells using carbon nanotube array electrode. Nanotechnology, 18 (46) More Information

Shi D.;Guo Y.;Dong Z.;Lian J.;Wang W.;Liu G.;Wang L.;Ewing R.  (11-19-2007). Quantum-dot-activated luminescent carbon nanotubes via a nano scale surface functionalization for in. Advanced Materials, 19 (22) , 4033-4037More Information

Yun Y.;Dong Z.;Shanov V.;Bange A.;Heineman W.;Halsall H.;Conforti L.;Bhattacharya A.;Schulz M.  (11-01-2007). On-line carbon nanotube-based biosensors in microfluidic channels. Proceedings of SPIE - The International Society for Optical Engineering, 6528More Information

Guo Y.;Wang W.;Cho H.S.;Lian J.;Ewing R.;Wang L.;Liu G.K.;Dong Z.Y.;Shi D.  (08-23-2007). Luminescent carbon nanotubes for biomedical diagnosis and treatment. 2007 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2007, Technical Proceedings, 2, 251-254

Yun Y.H.;Bange A.;Heineman W.R.;Halsall H.B.;Shanov V.N.;Dong Z.;Pixley S.;Behbehani M.;Jazieh A.;Tu Y.;Wong D.K.Y.;Bhattacharya A.;Schulz M.J.  (04-10-2007). A nanotube array immunosensor for direct electrochemical detection of antigen-antibody binding. Sensors and Actuators, B: Chemical, 123 (1) , 177-182More Information

Yun Y.H.;Shanov V.;Schulz M.J.;Dong Z.;Jazieh A.;Heineman W.R.;Halsall H.B.;Wong D.K.Y.;Bange A.;Tu Y.;Subramaniam S.  (12-14-2006). High sensitivity carbon nanotube tower electrodes. Sensors and Actuators, B: Chemical, 120 (1) , 298-304More Information

Yun Y.H.;Bange A.;Shanov V.N.;Heineman W.R.;Brian Halsall H.;Dong Z.;Jazieh A.;Tu Y.;Wong D.;Pixley S.;Behbehani M.;Schulz M.J.  (12-01-2006). Fabrication and characterization of a multiwall carbon nanotube needle biosensor. 2006 6th IEEE Conference on Nanotechnology, IEEE-NANO 2006, 1, 280-283

Shi D.;Guo Y.;Wang W.;Cho H.;Lian J.;Wang L.;Ewing R.G.;Liu G.;Dong Z.  (11-28-2006). Deposition of rare-earth doped nanophosphors on multi-wall carbon nanotube surfaces - a new approach. Proceedings of the International Conference on Manufacturing Science and Engineering, 2006

Yun Y.;Bange A.;Shanov V.;Heineman W.;Brian Halsall H.;Pixley S.;Behbehani M.;Dong Z.;Tu Y.;Yarmolenko S.;Neralla S.;Schulz M.  (07-20-2006). Carbon nanotube array smart materials. Proceedings of SPIE - The International Society for Optical Engineering, 6172More Information

Olson M.;Lee J.;Zhang F.;Wang A.;Dong Z.  (07-17-2006). Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by in. Cancer Gene Therapy, 13 (7) , 676-685More Information

Yun Y.;Schulz M.;Bange A.;Heineman W.;Halsall H.;Shanov V.;Behbehani M.;Pixley S.;Bhattacharya A.;Dong Z.;Wong D.  (06-01-2006). A nanotube composite microelectrode for monitoring dopamine levels using cyclic voltammetry and diff. Proceedings of the Institution of Mechanical Engineers, Part N: Journal of Nanoengineering and Nanosystems, 220 (2) , 53-60More Information

Shi D.;Lian J.;Wang W.;Liu G.;He P.;Dong Z.;Wang L.;Ewing R.  (01-19-2006). Luminescent carbon nanotubes by surface functionalization. Advanced Materials, 18 (2) , 189-193More Information

Lu W.;Dong Z.;Donawho C.;Fidler I.  (08-01-2002). ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric ca. International Journal of Cancer, 100 (4) , 486-490More Information

Cao G.;Su J.;Lu W.;Zhang F.;Zhao G.;Marteralli D.;Dong Z.  (01-01-2002). Multiple arteriovenous malformations with hemorrhage. Acta Neurochirurgica, 144 (1) , 97-101More Information

Zhang F.;Zhao G.;Dong Z.  (07-07-2001). Phosphatidylcholine-specific phospholipase C regulates activation of RAW264.7 macrophage-like cells . Journal of Leukocyte Biology, 69 (6) , 1060-1066

Zhang F.;Zhao G.;Dong Z.  (06-21-2001). Phosphatidylcholine-specific phospholipase C and D in stimulation of RAW264.7 mouse macrophage-like . International Immunopharmacology, 1 (7) , 1375-1384More Information

Cao G.;Su J.;Lu W.;Zhang F.;Zhao G.;Marteralli D.;Dong Z.  (01-01-2001). Adenovirus-mediated interferon-? gene therapy suppresses growth and metastasis of human prostate can. Cancer Gene Therapy, 8 (7) , 497-505More Information

Fidler I.J.;Singh R.K.;Yoneda J.;Kumar R.;Xu L.;Dong Z.;Bielenberg D.R.;McCarty M.;Ellis L.M.  (05-01-2000). Critical determinants of neoplastic angiogenesis. Cancer Journal, 6 (SUPPL. 3)

Kumar R.;Xie K.;Eue I.;Dong Z.;Killion J.;Fidler I.  (01-01-2000). Differential regulation of type IV collagenases and metalloelastase in murine macrophages by the syn. International Journal of Immunopharmacology, 22 (6) , 431-443More Information

Bruns C.;Shinohara H.;Harbison M.;Davis D.;Nelkin G.;Killion J.;McConkey D.;Dong Z.;Fidler I.  (01-01-2000). Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 i. Cancer Research, 60 (1) , 2-7

Lu W.;Fidler I.;Dong Z.  (10-15-1999). Eradication of primary murine fibrosarcomas and induction of systemic immunity by adenovirus mediate. Cancer Research, 59 (20) , 5202-5208

Dong Z.;Greene G.;Pettaway C.;Dinney C.;Eue I.;Lu W.;Bucana C.;Balbay M.;Bielenberg D.;Fidler I.  (02-15-1999). Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineere. Cancer Research, 59 (4) , 872-879

Kumar R.;Yoneda J.;Fidler I.J.;Dong Z.  (01-01-1999). GM-CSF-transduced B16 melanoma cells are highly susceptible to lysis by normal murine macrophages an. Journal of Leukocyte Biology, 65 (1) , 102-108More Information

Dong Z.;Yoneda J.;Kumar R.;Fidler I.J.  (08-17-1998). Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce gra. Journal of Experimental Medicine, 188 (4) , 755-763More Information

Eue I.;Kumar R.;Dong Z.;Killion J.;Fidler I.  (01-01-1998). Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synth. Journal of Immunotherapy, 21 (5) , 340-351More Information

Dong Z.;Killion J.;Kumar R.;Eue I.;Yang X.;Lu W.;Su B.;Fidler I.  (01-01-1998). Activation of cytokine production, tumoricidal properties, and tyrosine phosphorylation of MAPKs in . Journal of Leukocyte Biology, 63 (6) , 766-774More Information

Dong Z.;Juang S.;Kumar R.;Eue I.;Xie K.;Bielenberg D.;Lu W.;Bucana C.;Yang X.;Fidler I.  (01-01-1998). Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with . Cancer Immunology Immunotherapy, 46 (3) , 137-146More Information

Xie K.;Bielenberg D.;Huang S.;Xu L.;Salas T.;Juang S.;Dong Z.;Fidler I.  (12-01-1997). Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the. Clinical Cancer Research, 3 (12 I) , 2283-2294

Dong Z.;Kumar R.;Yang X.;Fidler I.  (03-21-1997). Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung ca. Cell, 88 (6) , 801-810More Information

Xie K.;Huang S.;Dong Z.;Juang S.;Wang Y.;Fidler I.  (03-19-1997). Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase . Journal of the National Cancer Institute, 89 (6) , 421-427More Information

Dong Z.;Yang X.;Fidler I.  (01-01-1997). Neutralization of endogenous interferon-? increases the efficiency of adenoviral vector-mediated gen. Journal of Interferon and Cytokine Research, 17 (7) , 401-407More Information

Kumar R.;Eue I.;Dong Z.;Killion J.;Fidler I.  (01-01-1997). Expression of inflammatory cytokines by murine macrophages activated with a new synthetic lipopeptid. Cancer Biotherapy and Radiopharmaceuticals, 12 (5) , 333-340More Information

Wei Q.;Cheng L.;Xie K.;Bucana C.;Dong Z.  (01-01-1997). Direct correlation between DNA repair capacity and metastatic potential of K-1735 murine melanoma ce. Journal of Investigative Dermatology, 108 (1) , 3-6More Information

Dinney C.;Parker C.;Dong Z.;Fan D.;Eve B.;Bucana C.;Radinsky R.  (01-01-1997). Therapy of human transitioneal cell carcinoma of the bladder by oral administration of the epidermal. Clinical Cancer Research, 3 (2) , 161-168

Kumar R.;Dong Z.;Fidler I.  (12-01-1996). Differential Regulation of Metalloelastase Activity in Murine Peritoneal Macrophages by Granulocyte-. Journal of Immunology, 157 (11) , 5104-5111

Xie K.;Huang S.;Wang Y.;Beltran P.;Juang S.;Dong Z.;Reed J.;McDonnell T.;McConkey D.;Fidler I.  (11-27-1996). Bcl-2 protects cells from cytokine-induced nitric-oxide-dependent apoptosis. Cancer Immunology Immunotherapy, 43 (2) , 109-115More Information

Xie K.;Dong Z.;Fidler I.  (01-01-1996). Activation of nitric oxide synthase gene for inhibition of cancer metastasis. Journal of Leukocyte Biology, 59 (6) , 797-803More Information

Killion J.;Bucana C.;Radinsky R.;Dong Z.;O'Reilly T.;Bilbe G.;Tarcsay L.;Fidler I.  (01-01-1996). Maintenance of intestinal epithelium structural integrity and mucosal leukocytes during chemotherapy. Cancer Biotherapy and Radiopharmaceuticals, 11 (6) , 363-371More Information

Xie K.;Huang S.;Dong Z.;Gutman M.;Fidler I.  (07-15-1995). Direct Correlation between Expression of Endogenous Inducible Nitric Oxide Synthase and Regression o. Cancer Research, 55 (14) , 3123-3131

Xie K.;Huang S.;Dong Z.;Juang S.;Gutman M.;Xie Q.;Nathan C.;Fidler I.  (04-01-1995). Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates m. Journal of Experimental Medicine, 181 (4) , 1333-1343More Information

Dong Z.;Yang X.;Xie K.;Juang S.;Llansa N.;Fidler I.  (01-01-1995). Activation of inducible nitric oxide synthase gene in murine macrophages requires protein phosphatas. Journal of Leukocyte Biology, 58 (6) , 725-732More Information

Radinsky R.;Risin S.;Fan D.;Dong Z.;Bielenberg D.;Bucana C.;Fidler I.  (01-01-1995). Level and Function of Epidermal Growth Factor Receptor Predict the Metastatic Potential of Human Col. Clinical Cancer Research, 1 (1) , 19-31

Dong Z.;Radinsky R.;Fan D.;Tsan R.;Bucana C.D.;Wilmanns C.;Fidler I.J.  (06-15-1994). Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon ca. Journal of the National Cancer Institute, 86 (12) , 913-920More Information

Fidler I.J.;Wilmanns C.;Staroselsky A.;Radinsky R.;Dong Z.;Fan D.  (06-01-1994). Modulation of tumor cell response to chemotherapy by the organ environment. Cancer and Metastasis Reviews, 13 (2) , 209-222More Information

Xie B.;Dong Z.;Fidler I.  (04-01-1994). Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. Journal of Immunology, 152 (7) , 3637-3644

Dong Z.;Staroselsky A.;Qi X.;Xie K.;Fidler I.  (01-01-1994). Inverse Correlation between Expression of Inducible Nitric Oxide Synthase Activity and Production of. Cancer Research, 54 (3) , 789-793

Fan D.;Poste G.;Ruffolo R.;Dong Z.;Seid C.;Earnest L.;Campbell T.;Clyne R.;Beltran P.;Fidler I.  (01-01-1994). Circumvention of multidrug resistance in murine fibrosarcoma and colon carcinoma cells by treatment . International Journal of Oncology, 4 (4) , 789-798

Killion J.;Radinsky R.;Dong Z.;Fishbeck R.;Whitworth P.;Fidler I.  (11-01-1993). The immunogenic properties of drug-resistant murine tumor cells do not correlate with expression of . Cancer Immunology Immunotherapy, 36 (6) , 381-386More Information

Dong Z.;Qi X.;Fidler I.  (04-01-1993). Tyrosine phosphorylation of mitogen-activated protein kinases is necessary for activation of murine . Journal of Experimental Medicine, 177 (4) , 1071-1077More Information

Dong Z.;O'Brian C.;Fidler I.  (01-01-1993). Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine . Journal of Leukocyte Biology, 53 (1) , 53-60More Information

Xie K.;Huang S.;Dong Z.;Fidler I.J.  (01-01-1993). Cytokine-induced apoptosis in transformed murine fibroblasts involves synthesis of endogenous nitric. International Journal of Oncology, 3 (6) , 1043-1048

Dong Z.;Qi X.;Xie K.;Fidler I.  (01-01-1993). Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolys. Journal of Immunology, 151 (5) , 2717-2724

Bucana C.;Radinsky R.;Dong Z.;Sanchez R.;Brigati D.;Fidler I.  (01-01-1993). A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide pr. Journal of Histochemistry and Cytochemistry, 41 (4) , 499-506More Information

O'Brian C.A.;Fan D.;Ward N.E.;Dong Z.;Iwamoto L.;Gupta K.P.;Earnest L.E.;Fidler I.J.  (03-01-1991). Transient enhancement of multidrug resistance by the bile acid deoxycholate in murine fibrosarcoma c. Biochemical Pharmacology, 41 (5) , 797-806More Information

Dong Z.;Ward N.E.;Fan D.;Gupta K.P.;O'Brian C.A.  (01-01-1991). In vitro model for intrinsic drug resistance: Effects of protein kinase C activators on the chemosen. Molecular Pharmacology, 39 (4) , 563-569

Dong Z.;Lu S.;Zhang Y.  (01-01-1989). Effects of Pretreatment with Protein Kinase C Activators on Macrophage Activation for Tumor Cytotoxi. Immunobiology, 179 (4-5) , 382-394More Information

Dong Z.Y.;Zhang Y.H.  (01-01-1987). Inhibitory effect of a mycotoxin, Fusarin C, on macrophage activation and macrophage mediated cytoto. Journal of Experimental and Clinical Cancer Research, 6 (1) , 31-38

1990 Science Advance Award Chinese Academy of Medical Sciences

angiostatin, angiogenesis, IFN-b gene, prostate cancer, tumorigenicity, PCNA inhibitor, androgen receptor inhibitor, androgen receptor

Academic - Vontz Center for Molecular Studies
3125 Eden Avenue, Room 1308
Cincinnati  Ohio, 45267-0508
Phone: 513-558-2176
Fax: 513-558-6703
zhongyun.dong@uc.edu